Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Obstructive Lung Diseases

  Free Subscription

Articles published in Respir Res

Retrieve available abstracts of 264 articles:
HTML format

Single Articles

    May 2020
  1. XU W, Wang Y, Ma Y, Yang J, et al
    MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome.
    Respir Res. 2020;21:116.
    PubMed     Abstract available

  2. WEIDNER J, Ekerljung L, Malmhall C, Miron N, et al
    Circulating microRNAs correlate to clinical parameters in individuals with allergic and non-allergic asthma.
    Respir Res. 2020;21:107.
    PubMed     Abstract available

  3. OCCHIPINTI M, Paoletti M, Crapo JD, Make BJ, et al
    Validation of a method to assess emphysema severity by spirometry in the COPDGene study.
    Respir Res. 2020;21:103.
    PubMed     Abstract available

    April 2020
  4. LI W, Gao R, Xin T, Gao P, et al
    Different expression levels of interleukin-35 in asthma phenotypes.
    Respir Res. 2020;21:89.
    PubMed     Abstract available

  5. WATZ H, Hohlfeld JM, Singh D, Beier J, et al
    Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
    Respir Res. 2020;21:87.
    PubMed     Abstract available

    March 2020
  6. GOVONI M, Bassi M, Vezzoli S, Lucci G, et al
    Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
    Respir Res. 2020;21:72.
    PubMed     Abstract available

    February 2020
  7. MAO S, Wu L, Shi W
    Prevalence and distribution patterns of allergens among children with asthma and asthma-like symptoms in Shanghai, China.
    Respir Res. 2020;21:57.
    PubMed     Abstract available

  8. PINDUS M, Orru H, Jogi R
    Change in the symptom profile treated as asthma - two cross-sectional studies twenty years apart.
    Respir Res. 2020;21:41.
    PubMed     Abstract available

    January 2020
  9. MOUI A, Klein M, Hassoun D, Dijoux E, et al
    The IL-15 / sIL-15Ralpha complex modulates immunity without effect on asthma features in mouse.
    Respir Res. 2020;21:33.
    PubMed     Abstract available

  10. MCGEACHIE MJ, Sordillo JE, Dahlin A, Wang AL, et al
    Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy.
    Respir Res. 2020;21:31.
    PubMed     Abstract available

  11. VOGELBERG C, Goldstein S, Graham L, Kaplan A, et al
    A comparison of tiotropium, long-acting beta2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma.
    Respir Res. 2020;21:19.
    PubMed     Abstract available

  12. ARTARAZ A, Crichton ML, Finch S, Abo-Leyah H, et al
    Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST).
    Respir Res. 2020;21:18.
    PubMed     Abstract available

  13. LIAO Y, Li P, Wang Y, Chen H, et al
    Construction of asthma related competing endogenous RNA network revealed novel long non-coding RNAs and potential new drugs.
    Respir Res. 2020;21:14.
    PubMed     Abstract available

  14. DENHOLM R, van der Werf ET, Hay AD
    Use of antibiotics and asthma medication for acute lower respiratory tract infections in people with and without asthma: retrospective cohort study.
    Respir Res. 2020;21:4.
    PubMed     Abstract available

    December 2019
  15. IBRAHIM H, O'Sullivan R, Casey D, Murphy J, et al
    The effectiveness of Reslizumab in severe asthma treatment: a real-world experience.
    Respir Res. 2019;20:289.
    PubMed     Abstract available

  16. LEAKER BR, Singh D, Lindgren S, Almqvist G, et al
    Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study.
    Respir Res. 2019;20:288.
    PubMed     Abstract available

  17. CHEN YF, Huang G, Wang YM, Cheng M, et al
    Exchange protein directly activated by cAMP (Epac) protects against airway inflammation and airway remodeling in asthmatic mice.
    Respir Res. 2019;20:285.
    PubMed     Abstract available

  18. KIM SH, Pei QM, Jiang P, Liu J, et al
    Upregulation of MUC5AC by VEGF in human primary bronchial epithelial cells: implications for asthma.
    Respir Res. 2019;20:282.
    PubMed     Abstract available

  19. GOUSSAULT H, Salvator H, Catherinot E, Chabi ML, et al
    Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center.
    Respir Res. 2019;20:275.
    PubMed     Abstract available

  20. SIN S, Yun SY, Kim JM, Park CM, et al
    Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis.
    Respir Res. 2019;20:271.
    PubMed     Abstract available

    November 2019
  21. VANDERS RL, Hsu A, Gibson PG, Murphy VE, et al
    Nasal epithelial cells to assess in vitro immune responses to respiratory virus infection in pregnant women with asthma.
    Respir Res. 2019;20:259.
    PubMed     Abstract available

  22. HAKANSSON KEJ, Rasmussen LJH, Godtfredsen NS, Tupper OD, et al
    The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study.
    Respir Res. 2019;20:258.
    PubMed     Abstract available

    October 2019
  23. HADDAD A, Gaudet M, Plesa M, Allakhverdi Z, et al
    Neutrophils from severe asthmatic patients induce epithelial to mesenchymal transition in healthy bronchial epithelial cells.
    Respir Res. 2019;20:234.
    PubMed     Abstract available

  24. HOSSEINI M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S, et al
    Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis.
    Respir Res. 2019;20:229.
    PubMed     Abstract available

  25. BAK SH, Kwon SO, Han SS, Kim WJ, et al
    Computed tomography-derived area and density of pectoralis muscle associated disease severity and longitudinal changes in chronic obstructive pulmonary disease: a case control study.
    Respir Res. 2019;20:226.
    PubMed     Abstract available

  26. NADER CP, Cidem A, Verrills NM, Ammit AJ, et al
    Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer.
    Respir Res. 2019;20:222.
    PubMed     Abstract available

  27. PINTO-PLATA V, Casanova C, Divo M, Tesfaigzi Y, et al
    Plasma metabolomics and clinical predictors of survival differences in COPD patients.
    Respir Res. 2019;20:219.
    PubMed     Abstract available

  28. KIRSCH F, Schramm A, Schwarzkopf L, Lutter JI, et al
    Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.
    Respir Res. 2019;20:215.
    PubMed     Abstract available

  29. LIU J, Dong YQ, Yin J, Yao J, et al
    Meta-analysis of vitamin D and lung function in patients with asthma.
    Respir Res. 2019;20:161.
    PubMed     Abstract available

    September 2019
  30. BONNARDEL E, Prevel R, Campagnac M, Dubreuil M, et al
    Determination of reliable lung function parameters in intubated mice.
    Respir Res. 2019;20:211.
    PubMed     Abstract available

  31. KO FW, Chan PK, Chan RWY, Chan KP, et al
    Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease.
    Respir Res. 2019;20:210.
    PubMed     Abstract available

  32. AKIKI Z, Andrianjafimasy M, Zerimech F, Le Moual N, et al
    High level of fluorescent oxidation products and worsening of asthma control over time.
    Respir Res. 2019;20:203.
    PubMed     Abstract available

  33. LIANG X, He X, Li Y, Wang J, et al
    Lyn regulates epithelial-mesenchymal transition in CS-exposed model through Smad2/3 signaling.
    Respir Res. 2019;20:201.
    PubMed     Abstract available

  34. WELLMERLING JH, Chang SW, Kim E, Osman WH, et al
    Reduced expression of the Ion channel CFTR contributes to airspace enlargement as a consequence of aging and in response to cigarette smoke in mice.
    Respir Res. 2019;20:200.
    PubMed     Abstract available

    August 2019
  35. MOURONTE-ROIBAS C, Leiro-Fernandez V, Ruano-Ravina A, Ramos-Hernandez C, et al
    Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study.
    Respir Res. 2019;20:198.
    PubMed     Abstract available

  36. PASCOE SJ, Papi A, Midwinter D, Lettis S, et al
    Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:195.
    PubMed     Abstract available

  37. ZYSMAN M, Burgel PR, Court-Fortune I, Brinchault-Rabin G, et al
    Relationship between gender and survival in a real-life cohort of patients with COPD.
    Respir Res. 2019;20:191.
    PubMed     Abstract available

  38. SIDHAYE VK, Holbrook JT, Burke A, Sudini KR, et al
    Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD.
    Respir Res. 2019;20:190.
    PubMed     Abstract available

  39. ROCHE N, Antoniadis A, Hess D, Li PZ, et al
    Are there specific clinical characteristics associated with physician's treatment choices in COPD?
    Respir Res. 2019;20:189.
    PubMed     Abstract available

  40. ANDREAS S, Rover C, Heinz J, Straube S, et al
    Decline of COPD exacerbations in clinical trials over two decades - a systematic review and meta-regression.
    Respir Res. 2019;20:186.
    PubMed     Abstract available

  41. MUNESWARAO J, Hassali MA, Ibrahim B, Saini B, et al
    It is time to change the way we manage mild asthma: an update in GINA 2019.
    Respir Res. 2019;20:183.
    PubMed     Abstract available

  42. SINGH D, Beeh KM, Colgan B, Kornmann O, et al
    Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
    Respir Res. 2019;20:180.
    PubMed     Abstract available

  43. EDRIS A, De Feyter S, Maes T, Joos G, et al
    Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis.
    Respir Res. 2019;20:179.
    PubMed     Abstract available

  44. VOGELMEIER CF, Kostikas K, Fang J, Tian H, et al
    Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
    Respir Res. 2019;20:178.
    PubMed     Abstract available

  45. LEE KM, Lee G, Kim A, Mok J, et al
    Clinical outcomes of radial probe endobronchial ultrasound using a guide sheath for diagnosis of peripheral lung lesions in patients with pulmonary emphysema.
    Respir Res. 2019;20:177.
    PubMed     Abstract available

  46. TAKIGUCHI H, Chen V, Obeidat M, Hollander Z, et al
    Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial.
    Respir Res. 2019;20:176.
    PubMed     Abstract available

  47. LEATHER DA, Yates L, Svedsater H, Jacques L, et al
    Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?
    Respir Res. 2019;20:173.
    PubMed     Abstract available

    July 2019
  48. ALBERS FC, Papi A, Taille C, Bratton DJ, et al
    Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA.
    Respir Res. 2019;20:169.
    PubMed     Abstract available

  49. AGARWAL AR, Kadam S, Brahme A, Agrawal M, et al
    Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD).
    Respir Res. 2019;20:171.
    PubMed     Abstract available

  50. THULBORN SJ, Mistry V, Brightling CE, Moffitt KL, et al
    Neutrophil elastase as a biomarker for bacterial infection in COPD.
    Respir Res. 2019;20:170.
    PubMed     Abstract available

  51. KERWIN EM, Ferguson GT, Mo M, DeAngelis K, et al
    Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study.
    Respir Res. 2019;20:167.
    PubMed     Abstract available

  52. YANG J, Ramirez Moral I, van 't Veer C, de Vos AF, et al
    Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.
    Respir Res. 2019;20:165.
    PubMed     Abstract available

  53. ALDABAYAN YS, Ridsdale HA, Alrajeh AM, Aldhahir AM, et al
    Pulmonary rehabilitation, physical activity and aortic stiffness in COPD.
    Respir Res. 2019;20:166.
    PubMed     Abstract available

  54. KIM W, Cho MH, Sakornsakolpat P, Lynch DA, et al
    DSP variants may be associated with longitudinal change in quantitative emphysema.
    Respir Res. 2019;20:160.
    PubMed     Abstract available

  55. LIU G, Betts C, Cunoosamy DM, Aberg PM, et al
    Use of precision cut lung slices as a translational model for the study of lung biology.
    Respir Res. 2019;20:162.
    PubMed     Abstract available

  56. HALPIN DMG, Meltzer EO, Pisternick-Ruf W, Moroni-Zentgraf P, et al
    Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1.
    Respir Res. 2019;20:159.
    PubMed     Abstract available

  57. LANGTON D, Sloan G, Banks C, Bennetts K, et al
    Bronchial thermoplasty increases airway volume measured by functional respiratory imaging.
    Respir Res. 2019;20:157.
    PubMed     Abstract available

  58. CSOMA B, Bikov A, Nagy L, Toth B, et al
    Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD.
    Respir Res. 2019;20:156.
    PubMed     Abstract available

  59. HAGHIGHI B, Choi S, Choi J, Hoffman EA, et al
    Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS).
    Respir Res. 2019;20:153.
    PubMed     Abstract available

  60. TRUDZINSKI FC, Alqudrah M, Omlor A, Zewinger S, et al
    Consequences of chronic kidney disease in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:151.
    PubMed     Abstract available

  61. CRUZ T, Lopez-Giraldo A, Noell G, Casas-Recasens S, et al
    Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).
    Respir Res. 2019;20:152.
    PubMed     Abstract available

  62. PIGNATTI P, Visca D, Cherubino F, Zampogna E, et al
    Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Respir Res. 2019;20:145.
    PubMed     Abstract available

  63. TALBOOM-KAMP EPWA, Holstege MS, Chavannes NH, Kasteleyn MJ, et al
    Effects of use of an eHealth platform e-Vita for COPD patients on disease specific quality of life domains.
    Respir Res. 2019;20:146.
    PubMed     Abstract available

  64. MA Y, Tong H, Zhang X, Wang M, et al
    Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.
    Respir Res. 2019;20:144.
    PubMed     Abstract available

  65. SINGH D, D'Urzo AD, Donohue JF, Kerwin EM, et al
    Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective.
    Respir Res. 2019;20:141.
    PubMed     Abstract available

    June 2019
  66. LEAKER BR, Singh D, Nicholson GC, Hezelova B, et al
    Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease.
    Respir Res. 2019;20:132.
    PubMed     Abstract available

  67. O'BRIEN ME, Chandra D, Wilson RC, Karoleski CM, et al
    Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers.
    Respir Res. 2019;20:128.
    PubMed     Abstract available

  68. VEIL-PICARD M, Soumagne T, Vongthilath R, Annesi-Maesano I, et al
    Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers?
    Respir Res. 2019;20:124.
    PubMed     Abstract available

  69. LIU F, Qu F, Zhang H, Chao L, et al
    The effect and burden modification of heating on adult asthma hospitalizations in Shijiazhuang: a time-series analysis.
    Respir Res. 2019;20:122.
    PubMed     Abstract available

  70. ZHAO J, Li M, Wang Z, Chen J, et al
    Role of PM2.5 in the development and progression of COPD and its mechanisms.
    Respir Res. 2019;20:120.
    PubMed     Abstract available

  71. GERN JE, Jackson DJ, Lemanske RF Jr, Seroogy CM, et al
    The Children's Respiratory and Environmental Workgroup (CREW) birth cohort consortium: design, methods, and study population.
    Respir Res. 2019;20:115.
    PubMed     Abstract available

  72. PRAGMAN AA, Knutson KA, Gould TJ, Isaacson RE, et al
    Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Respir Res. 2019;20:114.
    PubMed     Abstract available

  73. WANG Z, Maschera B, Lea S, Kolsum U, et al
    Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:113.
    PubMed     Abstract available

    May 2019
  74. NELSEN LM, Lee LA, Wu W, Lin X, et al
    Reliability, validity and responsiveness of E-RS:COPD in patients with spirometric asthma-COPD overlap.
    Respir Res. 2019;20:107.
    PubMed     Abstract available

  75. XIONG XF, Zhu M, Wu HX, Fan LL, et al
    Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials.
    Respir Res. 2019;20:108.
    PubMed     Abstract available

  76. ROGLIANI P, Matera MG, Page C, Puxeddu E, et al
    Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
    Respir Res. 2019;20:104.
    PubMed     Abstract available

  77. UM-BERGSTROM P, Hallberg J, Pourbazargan M, Berggren-Brostrom E, et al
    Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma.
    Respir Res. 2019;20:102.
    PubMed     Abstract available

  78. OCCHIPINTI M, Paoletti M, Bartholmai BJ, Rajagopalan S, et al
    Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD.
    Respir Res. 2019;20:101.
    PubMed     Abstract available

  79. LIU L, Zhang X, Liu Y, Zhang L, et al
    Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
    Respir Res. 2019;20:95.
    PubMed     Abstract available

  80. KARMAUS W, Mukherjee N, Janjanam VD, Chen S, et al
    Distinctive lung function trajectories from age 10 to 26 years in men and women and associated early life risk factors - a birth cohort study.
    Respir Res. 2019;20:98.
    PubMed     Abstract available

  81. MCDONALD MN, Wouters EFM, Rutten E, Casaburi R, et al
    It's more than low BMI: prevalence of cachexia and associated mortality in COPD.
    Respir Res. 2019;20:100.
    PubMed     Abstract available

  82. RODRIGUES FM, Demeyer H, Loeckx M, Hornikx M, et al
    Health status deterioration in subjects with mild to moderate airflow obstruction, a six years observational study.
    Respir Res. 2019;20:93.
    PubMed     Abstract available

  83. LI N, He Y, Yang G, Yu Q, et al
    Role of TRPC1 channels in pressure-mediated activation of airway remodeling.
    Respir Res. 2019;20:91.
    PubMed     Abstract available

  84. TRABELSI S, Casas L, Nemery B, Nawrot TS, et al
    Geographies of asthma medication purchase for pre-schoolers in Belgium.
    Respir Res. 2019;20:90.

  85. MIHALTAN F, Adir Y, Antczak A, Porpodis K, et al
    Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study.
    Respir Res. 2019;20:89.
    PubMed     Abstract available

  86. FAWZY A, Anderson JA, Cowans NJ, Crim C, et al
    Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
    Respir Res. 2019;20:86.
    PubMed     Abstract available

  87. REN Y, Zhang Y, Fan L, Jiao Q, et al
    The cullin4A is up-regulated in chronic obstructive pulmonary disease patient and contributes to epithelial-mesenchymal transition in small airway epithelium.
    Respir Res. 2019;20:84.
    PubMed     Abstract available

  88. PRAZMA CM, Bel EH, Price RG, Bradford ES, et al
    Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
    Respir Res. 2019;20:83.
    PubMed     Abstract available

    April 2019
  89. KANG HR, Hong SH, Ha SY, Kim TB, et al
    Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea.
    Respir Res. 2019;20:80.
    PubMed     Abstract available

  90. TANABE N, Sato S, Oguma T, Shima H, et al
    Associations of airway tree to lung volume ratio on computed tomography with lung function and symptoms in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:77.
    PubMed     Abstract available

  91. TURA-CEIDE O, Pizarro S, Garcia-Lucio J, Ramirez J, et al
    Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:74.
    PubMed     Abstract available

  92. QI Q, Ailiyaer Y, Liu R, Zhang Y, et al
    Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial.
    Respir Res. 2019;20:73.
    PubMed     Abstract available

  93. FAIZ A, van den Berge M, Vermeulen CJ, Ten Hacken NHT, et al
    AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers.
    Respir Res. 2019;20:70.
    PubMed     Abstract available

  94. HO TW, Huang CT, Tsai YJ, Lien AS, et al
    Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:69.
    PubMed     Abstract available

  95. ZHU Z, Wang X, Li X, Lin Y, et al
    Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis.
    Respir Res. 2019;20:64.
    PubMed     Abstract available

  96. MORROW JD, Chase RP, Parker MM, Glass K, et al
    RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD.
    Respir Res. 2019;20:65.
    PubMed     Abstract available

  97. RONNOW SR, Sand JMB, Langholm LL, Manon-Jensen T, et al
    Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
    Respir Res. 2019;20:63.
    PubMed     Abstract available

    March 2019
  98. LEE SH, Lee JH, Yoon HI, Park HY, et al
    Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
    Respir Res. 2019;20:62.
    PubMed     Abstract available

  99. ALTER P, Watz H, Kahnert K, Rabe KF, et al
    Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD.
    Respir Res. 2019;20:61.
    PubMed     Abstract available

  100. NAYA I, Tombs L, Lipson DA, Boucot I, et al
    Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis.
    Respir Res. 2019;20:60.
    PubMed     Abstract available

  101. HIGHAM A, Quinn AM, Cancado JED, Singh D, et al
    The pathology of small airways disease in COPD: historical aspects and future directions.
    Respir Res. 2019;20:49.
    PubMed     Abstract available

    February 2019
  102. KHAKBAN A, FitzGerald JM, Tavakoli H, Lynd L, et al
    Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study.
    Respir Res. 2019;20:44.
    PubMed     Abstract available

  103. STOEL BC, Stolk J, Bakker ME, Parr DG, et al
    Regional lung densities in alpha-1 antitrypsin deficiency compared to predicted values.
    Respir Res. 2019;20:45.
    PubMed     Abstract available

  104. SUGAWARA H, Saito A, Yokoyama S, Tsunematsu K, et al
    Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system.
    Respir Res. 2019;20:41.
    PubMed     Abstract available

  105. ZILAEE M, Hosseini SA, Jafarirad S, Abolnezhadian F, et al
    An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial.
    Respir Res. 2019;20:39.
    PubMed     Abstract available

  106. LI HF, Yan LP, Wang K, Li XT, et al
    Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis.
    Respir Res. 2019;20:38.
    PubMed     Abstract available

  107. BROWN MN, Fuhr R, Beier J, Su HL, et al
    Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial.
    Respir Res. 2019;20:37.
    PubMed     Abstract available

  108. FLEXEDER C, Zock JP, Jarvis D, Verlato G, et al
    Second-hand smoke exposure in adulthood and lower respiratory health during 20 year follow up in the European Community Respiratory Health Survey.
    Respir Res. 2019;20:33.
    PubMed     Abstract available

  109. CORSICO AG, D'Armini AM, Conio V, Sciortino A, et al
    Persistent exercise limitation after successful pulmonary endoarterectomy: frequency and determinants.
    Respir Res. 2019;20:34.
    PubMed     Abstract available

  110. VON SIEMENS SM, Jorres RA, Behr J, Alter P, et al
    Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    Respir Res. 2019;20:30.
    PubMed     Abstract available

  111. SUN SW, Chen L, Zhou M, Wu JH, et al
    BAMBI regulates macrophages inducing the differentiation of Treg through the TGF-beta pathway in chronic obstructive pulmonary disease.
    Respir Res. 2019;20:26.
    PubMed     Abstract available

    January 2019
  112. ZHOU T, Huang X, Ma J, Zhou Y, et al
    Association of plasma soluble CD14 level with asthma severity in adults: a case control study in China.
    Respir Res. 2019;20:19.
    PubMed     Abstract available

  113. LU Y, Chang R, Yao J, Xu X, et al
    Effectiveness of long-term using statins in COPD - a network meta-analysis.
    Respir Res. 2019;20:17.
    PubMed     Abstract available

  114. SRIDHAR S, Liu H, Pham TH, Damera G, et al
    Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases.
    Respir Res. 2019;20:14.
    PubMed     Abstract available

  115. KUBO F, Ariestanti DM, Oki S, Fukuzawa T, et al
    Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells.
    Respir Res. 2019;20:11.
    PubMed     Abstract available

  116. WEDZICHA JA, Singh D, Tsiligianni I, Jenkins C, et al
    Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.
    Respir Res. 2019;20:4.
    PubMed     Abstract available

  117. FANER R, Morrow JD, Casas-Recasens S, Cloonan SM, et al
    Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.
    Respir Res. 2019;20:5.
    PubMed     Abstract available

  118. ERRIAH M, Pabreja K, Fricker M, Baines KJ, et al
    Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma.
    Respir Res. 2019;20:1.
    PubMed     Abstract available

  119. MORICHIKA D, Miyahara N, Fujii U, Taniguchi A, et al
    A retinoid X receptor partial agonist attenuates pulmonary emphysema and airway inflammation.
    Respir Res. 2019;20:2.
    PubMed     Abstract available

    December 2018
  120. CRISAFULLI E, Ielpo A, Barbeta E, Ceccato A, et al
    Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.
    Respir Res. 2018;19:261.
    PubMed     Abstract available

  121. BHATT SP, Nath HP, Kim YI, Ramachandran R, et al
    Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Respir Res. 2018;19:257.
    PubMed     Abstract available

  122. GAFAR F, Boudewijn IM, Cox CA, Vonk JM, et al
    Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Res. 2018;19:256.
    PubMed     Abstract available

  123. WATZ H, Tetzlaff K, Magnussen H, Mueller A, et al
    Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Respir Res. 2018;19:251.
    PubMed     Abstract available

  124. LENOIR A, Fitting JW, Marques-Vidal PM, Vollenweider P, et al
    GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study.
    Respir Res. 2018;19:250.
    PubMed     Abstract available

  125. NEVILLE MDC, Choi J, Lieberman J, Duan QL, et al
    Identification of deleterious and regulatory genomic variations in known asthma loci.
    Respir Res. 2018;19:248.
    PubMed     Abstract available

  126. FLYNN RWV, MacDonald TM, Chalmers JD, Schembri S, et al
    The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
    Respir Res. 2018;19:249.
    PubMed     Abstract available

  127. ERIKSSON STROM J, Pourazar J, Linder R, Blomberg A, et al
    Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking.
    Respir Res. 2018;19:244.
    PubMed     Abstract available

  128. PEREZ-BAUTISTA O, Montano M, Perez-Padilla R, Zuniga-Ramos J, et al
    Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers.
    Respir Res. 2018;19:239.
    PubMed     Abstract available

  129. GREGORIANO C, Dieterle T, Breitenstein AL, Durr S, et al
    Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Respir Res. 2018;19:237.
    PubMed     Abstract available

    November 2018
  130. ROSCIOLI E, Hamon R, Lester SE, Jersmann HPA, et al
    Airway epithelial cells exposed to wildfire smoke extract exhibit dysregulated autophagy and barrier dysfunction consistent with COPD.
    Respir Res. 2018;19:234.
    PubMed     Abstract available

  131. LI F, Xu M, Wang M, Wang L, et al
    Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema.
    Respir Res. 2018;19:230.
    PubMed     Abstract available

  132. LEWIS TC, Metitiri EE, Mentz GB, Ren X, et al
    Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children.
    Respir Res. 2018;19:228.
    PubMed     Abstract available

  133. MILARA J, Diaz-Platas L, Contreras S, Ribera P, et al
    MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease.
    Respir Res. 2018;19:226.
    PubMed     Abstract available

  134. DRIESSEN MT, Whalen J, Seewoodharry Buguth B, Vallejo-Aparicio LA, et al
    Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
    Respir Res. 2018;19:224.
    PubMed     Abstract available

  135. XU W, Li R, Guan L, Wang K, et al
    Combination of inspiratory and expiratory muscle training in same respiratory cycle versus different cycles in COPD patients: a randomized trial.
    Respir Res. 2018;19:225.
    PubMed     Abstract available

  136. PIROZZI CS, Gu T, Quibrera PM, Carretta EE, et al
    Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
    Respir Res. 2018;19:223.
    PubMed     Abstract available

  137. NAYA IP, Tombs L, Muellerova H, Compton C, et al
    Long-term outcomes following first short-term clinically important deterioration in COPD.
    Respir Res. 2018;19:222.
    PubMed     Abstract available

  138. YANG J, Luo J, Yang L, Yang D, et al
    Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review.
    Respir Res. 2018;19:217.
    PubMed     Abstract available

  139. RUTTING S, Papanicolaou M, Xenaki D, Wood LG, et al
    Dietary omega-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD.
    Respir Res. 2018;19:211.
    PubMed     Abstract available

    October 2018
  140. HAYDEN LP, Cho MH, Raby BA, Beaty TH, et al
    Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study.
    Respir Res. 2018;19:209.
    PubMed     Abstract available

  141. LO D, Kennedy JL, Kurten RC, Panettieri RA Jr, et al
    Modulation of airway hyperresponsiveness by rhinovirus exposure.
    Respir Res. 2018;19:208.
    PubMed     Abstract available

  142. TASHKIN DP, Miravitlles M, Celli BR, Metzdorf N, et al
    Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT(R) trial.
    Respir Res. 2018;19:196.
    PubMed     Abstract available

    September 2018
  143. DOMINGO C, Palomares O, Sandham DA, Erpenbeck VJ, et al
    The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation.
    Respir Res. 2018;19:189.
    PubMed     Abstract available

  144. PARK HJ, Byun MK, Rhee CK, Kim K, et al
    Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
    Respir Res. 2018;19:185.
    PubMed     Abstract available

  145. KIRENGA BJ, Mugenyi L, de Jong C, Lucian Davis J, et al
    The impact of HIV on the prevalence of asthma in Uganda: a general population survey.
    Respir Res. 2018;19:184.
    PubMed     Abstract available

  146. STRODA A, Brandenburg V, Daher A, Cornelissen C, et al
    Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Respir Res. 2018;19:183.
    PubMed     Abstract available

  147. CRISFORD H, Sapey E, Stockley RA
    Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases.
    Respir Res. 2018;19:180.
    PubMed     Abstract available

  148. ZIYAB AH, Mukherjee N, Kurukulaaratchy RJ, Zhang H, et al
    Leptin receptor gene polymorphisms and sex modify the association between acetaminophen use and asthma among young adults: results from two observational studies.
    Respir Res. 2018;19:179.
    PubMed     Abstract available

  149. HAGHIGHI B, Choi S, Choi J, Hoffman EA, et al
    Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
    Respir Res. 2018;19:178.
    PubMed     Abstract available

  150. TONGA KO, King GG, Farah CS, Thamrin C, et al
    Steroid insensitive fixed airflow obstruction is not related to airway inflammation in older non-smokers with asthma.
    Respir Res. 2018;19:176.
    PubMed     Abstract available

  151. BARRECHEGUREN M, Gonzalez C, Miravitlles M
    What have we learned from observational studies and clinical trials of mild to moderate COPD?
    Respir Res. 2018;19:177.
    PubMed     Abstract available

  152. WINKLER A, Kahnert K, Behr J, Neurohr C, et al
    Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.
    Respir Res. 2018;19:171.
    PubMed     Abstract available

  153. JANSON C, Johansson G, Stallberg B, Lisspers K, et al
    Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.
    Respir Res. 2018;19:172.
    PubMed     Abstract available

  154. WATANABE M, Nakamoto K, Inui T, Sada M, et al
    Serum sST2 levels predict severe exacerbation of asthma.
    Respir Res. 2018;19:169.
    PubMed     Abstract available

  155. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Health care resource utilization and cost for asthma patients regularly treated with oral corticosteroids - a Swedish observational cohort study (PACEHR).
    Respir Res. 2018;19:168.
    PubMed     Abstract available

    August 2018
  156. MUELLER S, Gottschalk F, Groth A, Meeraus W, et al
    Primary data, claims data, and linked data in observational research: the case of COPD in Germany.
    Respir Res. 2018;19:161.
    PubMed     Abstract available

  157. MATUCCI A, Vultaggio A, Danesi R
    The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.
    Respir Res. 2018;19:154.
    PubMed     Abstract available

  158. BURBANK AJ, Todoric K, Steele P, Rosen J, et al
    Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics.
    Respir Res. 2018;19:152.
    PubMed     Abstract available

  159. GREULICH T, Rodriguez-Frias F, Belmonte I, Klemmer A, et al
    Real world evaluation of a novel lateral flow assay (AlphaKit(R) QuickScreen) for the detection of alpha-1-antitrypsin deficiency.
    Respir Res. 2018;19:151.
    PubMed     Abstract available

  160. ATANASOVA KR, Reznikov LR
    Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.
    Respir Res. 2018;19:149.
    PubMed     Abstract available

  161. JOHNSON KM, Tan WC, Bourbeau J, Sin DD, et al
    The diagnostic performance of patient symptoms in screening for COPD.
    Respir Res. 2018;19:147.
    PubMed     Abstract available

  162. REEVES SR, Kang I, Chan CK, Barrow KA, et al
    Asthmatic bronchial epithelial cells promote the establishment of a Hyaluronan-enriched, leukocyte-adhesive extracellular matrix by lung fibroblasts.
    Respir Res. 2018;19:146.
    PubMed     Abstract available

  163. MOHEIMANI F, Koops J, Williams T, Reid AT, et al
    Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics.
    Respir Res. 2018;19:145.
    PubMed     Abstract available

    July 2018
  164. WILLIAMS NP, Ostridge K, Devaster JM, Kim V, et al
    Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD.
    Respir Res. 2018;19:143.
    PubMed     Abstract available

  165. XU S, Tsai A, Sze MA, Vucic EA, et al
    Decreased microbiome diversity in the HIV small airway epithelium.
    Respir Res. 2018;19:140.
    PubMed     Abstract available

  166. STOCKLEY RA, Edgar RG, Starkey S, Turner AM, et al
    Health status decline in alpha-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?
    Respir Res. 2018;19:137.
    PubMed     Abstract available

  167. BARDSLEY G, Daley-Yates P, Baines A, Kempsford R, et al
    Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial.
    Respir Res. 2018;19:133.
    PubMed     Abstract available

  168. SHIN SH, Park HY, Kang D, Cho J, et al
    Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease.
    Respir Res. 2018;19:134.
    PubMed     Abstract available

    June 2018
  169. PHILPOTT CM, Erskine S, Hopkins C, Kumar N, et al
    Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study.
    Respir Res. 2018;19:129.
    PubMed     Abstract available

  170. BURGEL PR, Laurendeau C, Raherison C, Fuhrman C, et al
    An attempt at modeling COPD epidemiological trends in France.
    Respir Res. 2018;19:130.
    PubMed     Abstract available

  171. KHO AT, McGeachie MJ, Moore KG, Sylvia JM, et al
    Circulating microRNAs and prediction of asthma exacerbation in childhood asthma.
    Respir Res. 2018;19:128.
    PubMed     Abstract available

  172. XIN T, Chen M, Duan L, Xu Y, et al
    Interleukin-32: its role in asthma and potential as a therapeutic agent.
    Respir Res. 2018;19:124.
    PubMed     Abstract available

  173. ANZUETO AR, Kostikas K, Mezzi K, Shen S, et al
    Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
    Respir Res. 2018;19:121.
    PubMed     Abstract available

  174. ESTIRADO C, Ceccato A, Guerrero M, Huerta A, et al
    Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.
    Respir Res. 2018;19:119.
    PubMed     Abstract available

  175. TOLEDO-PONS N, Noell G, Jahn A, Iglesias A, et al
    Bone marrow characterization in COPD: a multi-level network analysis.
    Respir Res. 2018;19:118.
    PubMed     Abstract available

  176. XU S, Vucic EA, Shaipanich T, Lam S, et al
    Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV).
    Respir Res. 2018;19:117.
    PubMed     Abstract available

  177. MATUCCI A, Vultaggio A, Maggi E, Kasujee I, et al
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Respir Res. 2018;19:113.
    PubMed     Abstract available

  178. CARPAIJ OA, Muntinghe FOW, Wagenaar MB, Habing JW, et al
    Serum periostin does not reflect type 2-driven inflammation in COPD.
    Respir Res. 2018;19:112.
    PubMed     Abstract available

  179. VISHWESWARAIAH S, George L, Purushothaman N, Ganguly K, et al
    A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research.
    Respir Res. 2018;19:92.
    PubMed     Abstract available

  180. KAHNERT K, Alter P, Welte T, Huber RM, et al
    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach.
    Respir Res. 2018;19:110.
    PubMed     Abstract available

  181. SUN J, Gu X, Wu N, Zhang P, et al
    Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium.
    Respir Res. 2018;19:109.
    PubMed     Abstract available

  182. TWOREK D, Majewski S, Szewczyk K, Kiszalkiewicz J, et al
    The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Respir Res. 2018;19:108.
    PubMed     Abstract available

    May 2018
  183. JAAT FG, Hasan SF, Perry A, Cookson S, et al
    Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease.
    Respir Res. 2018;19:106.
    PubMed     Abstract available

  184. ALIAGAS E, Munoz-Esquerre M, Cuevas E, Careta O, et al
    Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD.
    Respir Res. 2018;19:103.
    PubMed     Abstract available

  185. FISK M, Cheriyan J, Mohan D, McEniery CM, et al
    Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.
    Respir Res. 2018;19:100.
    PubMed     Abstract available

  186. CLOOTS RHE, Poynter ME, Terwindt E, Lamers WH, et al
    Hypoargininemia exacerbates airway hyperresponsiveness in a mouse model of asthma.
    Respir Res. 2018;19:98.
    PubMed     Abstract available

  187. GODTFREDSEN NS, Jorgensen DV, Marsaa K, Ulrik CS, et al
    Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
    Respir Res. 2018;19:97.
    PubMed     Abstract available

  188. BELVISI MG, Baker K, Malloy N, Raemdonck K, et al
    Modelling the asthma phenotype: impact of cigarette smoke exposure.
    Respir Res. 2018;19:89.
    PubMed     Abstract available

  189. GAO YH, Cui JJ, Wang LY, Yin KQ, et al
    Arterial stiffness in adults with steady-state bronchiectasis: association with clinical indices and disease severity.
    Respir Res. 2018;19:86.
    PubMed     Abstract available

  190. BULSEI J, Leroy S, Perotin JM, Mal H, et al
    Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study).
    Respir Res. 2018;19:84.
    PubMed     Abstract available

  191. PERRY MM, Tildy B, Papi A, Casolari P, et al
    The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide.
    Respir Res. 2018;19:85.
    PubMed     Abstract available

    April 2018
  192. BLOECHLIGER M, Reinau D, Spoendlin J, Chang SC, et al
    Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis.
    Respir Res. 2018;19:75.
    PubMed     Abstract available

  193. SCHWARZKOPF L, Witt S, Waelscher J, Polke M, et al
    Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
    Respir Res. 2018;19:73.
    PubMed     Abstract available

  194. BERG T, Hegelund-Myrback T, Ockinger J, Zhou XH, et al
    Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals.
    Respir Res. 2018;19:68.
    PubMed     Abstract available

  195. LINDER R, Ronmark E, Pourazar J, Behndig AF, et al
    Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
    Respir Res. 2018;19:64.
    PubMed     Abstract available

  196. CHALMERS JD, Poole C, Webster S, Tebboth A, et al
    Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research
    Respir Res. 2018;19:63.
    PubMed     Abstract available

  197. DIAZ AA, Martinez CH, Harmouche R, Young TP, et al
    Pectoralis muscle area and mortality in smokers without airflow obstruction.
    Respir Res. 2018;19:62.
    PubMed     Abstract available

  198. OBEIDAT M, Zhou G, Li X, Hansel NN, et al
    The genetics of smoking in individuals with chronic obstructive pulmonary disease.
    Respir Res. 2018;19:59.
    PubMed     Abstract available

  199. GREULICH T, Hohlfeld JM, Neuser P, Lueer K, et al
    A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Respir Res. 2018;19:55.
    PubMed     Abstract available

    March 2018
  200. WANG J, Lv H, Luo Z, Mou S, et al
    Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
    Respir Res. 2018;19:47.
    PubMed     Abstract available

  201. VAN BUUL AR, Kasteleyn MJ, Chavannes NH, Taube C, et al
    Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms.
    Respir Res. 2018;19:49.
    PubMed     Abstract available

  202. SAKORNSAKOLPAT P, Morrow JD, Castaldi PJ, Hersh CP, et al
    Integrative genomics identifies new genes associated with severe COPD and emphysema.
    Respir Res. 2018;19:46.
    PubMed     Abstract available

  203. DE BROUWER B, Drent M, van den Ouweland JMW, Wijnen PA, et al
    Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.
    Respir Res. 2018;19:45.
    PubMed     Abstract available

  204. PADILLA-GALO A, Olveira C, Fernandez de Rota-Garcia L, Marco-Galve I, et al
    Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Respir Res. 2018;19:43.
    PubMed     Abstract available

  205. YANG M, Kohler M, Heyder T, Forsslund H, et al
    Proteomic profiling of lung immune cells reveals dysregulation of phagocytotic pathways in female-dominated molecular COPD phenotype.
    Respir Res. 2018;19:39.
    PubMed     Abstract available

  206. YANG M, Kohler M, Heyder T, Forsslund H, et al
    Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD.
    Respir Res. 2018;19:40.
    PubMed     Abstract available

  207. KERWIN EM, Spangenthal S, Kollar C, St Rose E, et al
    A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD.
    Respir Res. 2018;19:38.
    PubMed     Abstract available

  208. PARK HY, Lee SY, Kang D, Cho J, et al
    Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
    Respir Res. 2018;19:36.
    PubMed     Abstract available

  209. CASTELLO LM, Bellan M
    Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues.
    Respir Res. 2018;19:35.
    PubMed     Abstract available

    February 2018
  210. OSTRIDGE K, Williams NP, Kim V, Harden S, et al
    Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD.
    Respir Res. 2018;19:31.
    PubMed     Abstract available

  211. LEITAO FILHO FS, Ra SW, Mattman A, Schellenberg RS, et al
    Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD.
    Respir Res. 2018;19:30.
    PubMed     Abstract available

  212. JOHNSON KM, Bryan S, Ghanbarian S, Sin DD, et al
    Characterizing undiagnosed chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Respir Res. 2018;19:26.
    PubMed     Abstract available

    January 2018
  213. FAWZY A, Putcha N, Paulin LM, Aaron CP, et al
    Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.
    Respir Res. 2018;19:20.
    PubMed     Abstract available

  214. BREMNER PR, Birk R, Brealey N, Ismaila AS, et al
    Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study.
    Respir Res. 2018;19:19.
    PubMed     Abstract available

  215. MAHMUTOVIC PERSSON I, Menzel M, Ramu S, Cerps S, et al
    IL-1beta mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation.
    Respir Res. 2018;19:16.
    PubMed     Abstract available

  216. DI MARCO F, Sotgiu G, Santus P, O'Donnell DE, et al
    Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.
    Respir Res. 2018;19:18.
    PubMed     Abstract available

  217. LARSSON K, Stallberg B, Lisspers K, Telg G, et al
    Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR).
    Respir Res. 2018;19:12.
    PubMed     Abstract available

  218. OLLOQUEQUI J, Jaime S, Parra V, Cornejo-Cordova E, et al
    Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
    Respir Res. 2018;19:13.
    PubMed     Abstract available

  219. MIRAVITLLES M, Roche N, Cardoso J, Halpin D, et al
    Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
    Respir Res. 2018;19:11.
    PubMed     Abstract available

  220. USMANI OS, Lavorini F, Marshall J, Dunlop WCN, et al
    Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.
    Respir Res. 2018;19:10.
    PubMed     Abstract available

  221. MANORAK W, Idahosa C, Gupta K, Roy S, et al
    Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.
    Respir Res. 2018;19:1.
    PubMed     Abstract available

    December 2017
  222. BAO A, Yang H, Ji J, Chen Y, et al
    Involvements of p38 MAPK and oxidative stress in the ozone-induced enhancement of AHR and pulmonary inflammation in an allergic asthma model.
    Respir Res. 2017;18:216.
    PubMed     Abstract available

  223. GRAMEGNA A, Amati F, Terranova L, Sotgiu G, et al
    Neutrophil elastase in bronchiectasis.
    Respir Res. 2017;18:211.
    PubMed     Abstract available

  224. VARGAS A, Boivin R, Cano P, Murcia Y, et al
    Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Respir Res. 2017;18:207.
    PubMed     Abstract available

  225. KASTELEYN MJ, Bonten TN, de Mutsert R, Thijs W, et al
    Pulmonary function, exhaled nitric oxide and symptoms in asthma patients with obesity: a cross-sectional study.
    Respir Res. 2017;18:205.
    PubMed     Abstract available

  226. WANG G, Zhang X, Zhang HP, Wang L, et al
    Corticosteroid plus beta2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
    Respir Res. 2017;18:203.
    PubMed     Abstract available

    November 2017
  227. LO CY, Michaeloudes C, Bhavsar PK, Huang CD, et al
    Reduced suppressive effect of beta2-adrenoceptor agonist on fibrocyte function in severe asthma.
    Respir Res. 2017;18:194.
    PubMed     Abstract available

  228. ZHANG L, Zhang J, Gao P
    The potential of interleukin-37 as an effective therapeutic agent in asthma.
    Respir Res. 2017;18:192.
    PubMed     Abstract available

  229. DESCHILDRE A, Pichavant M, Engelmann I, Langlois C, et al
    Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
    Respir Res. 2017;18:191.
    PubMed     Abstract available

  230. ROCHA NN, de Oliveira MV, Braga CL, Guimaraes G, et al
    Ghrelin therapy improves lung and cardiovascular function in experimental emphysema.
    Respir Res. 2017;18:185.
    PubMed     Abstract available

  231. PEREZ-DE-LLANO L, Cosio BG
    Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
    Respir Res. 2017;18:183.
    PubMed     Abstract available

    September 2017
  232. MENENDEZ R, Mendez R, Polverino E, Rosales-Mayor E, et al
    Factors associated with hospitalization in bronchiectasis exacerbations: a one-year follow-up study.
    Respir Res. 2017;18:176.
    PubMed     Abstract available

  233. TORAIH EA, Hussein MH, Al Ageeli E, Riad E, et al
    Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma.
    Respir Res. 2017;18:169.
    PubMed     Abstract available

    May 2017
  234. RAVI AK, Plumb J, Gaskell R, Mason S, et al
    COPD monocytes demonstrate impaired migratory ability.
    Respir Res. 2017;18:90.
    PubMed     Abstract available

  235. PUNEKAR YS, Sharma S, Pahwa A, Takyar J, et al
    Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
    Respir Res. 2017;18:86.
    PubMed     Abstract available

  236. KOLSUM U, Donaldson GC, Singh R, Barker BL, et al
    Blood and sputum eosinophils in COPD; relationship with bacterial load.
    Respir Res. 2017;18:88.
    PubMed     Abstract available

  237. DOMINGO E, Grignola JC, Aguilar R, Messeguer ML, et al
    Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
    Respir Res. 2017;18:85.
    PubMed     Abstract available

  238. BODAS M, Vij N
    Augmenting autophagy for prognosis based intervention of COPD-pathophysiology.
    Respir Res. 2017;18:83.
    PubMed     Abstract available

  239. LAKHDAR R, Drost EM, MacNee W, Bastos R, et al
    2D-DIGE proteomic analysis of vastus lateralis from COPD patients with low and normal fat free mass index and healthy controls.
    Respir Res. 2017;18:81.
    PubMed     Abstract available

  240. MURRAY LA, Dunmore R, Camelo A, Da Silva CA, et al
    Acute cigarette smoke exposure activates apoptotic and inflammatory programs but a second stimulus is required to induce epithelial to mesenchymal transition in COPD epithelium.
    Respir Res. 2017;18:82.
    PubMed     Abstract available

  241. DUIVERMAN ML, Maagh P, Magnet FS, Schmoor C, et al
    Impact of High-Intensity-NIV on the heart in stable COPD: a randomised cross-over pilot study.
    Respir Res. 2017;18:76.
    PubMed     Abstract available

  242. WEIDNER J, Jarenback L, de Jong K, Vonk JM, et al
    Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
    Respir Res. 2017;18:77.
    PubMed     Abstract available

    April 2017
  243. OBEIDAT M, Nie Y, Chen V, Shannon CP, et al
    Network-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:72.
    PubMed     Abstract available

  244. MIRAVITLLES M, Ribera A
    Understanding the impact of symptoms on the burden of COPD.
    Respir Res. 2017;18:67.
    PubMed     Abstract available

  245. MATSUI H, Jo T, Fushimi K, Yasunaga H, et al
    Outcomes after early and delayed rehabilitation for exacerbation of chronic obstructive pulmonary disease: a nationwide retrospective cohort study in Japan.
    Respir Res. 2017;18:68.
    PubMed     Abstract available

  246. KHALAF RM, Lea SR, Metcalfe HJ, Singh D, et al
    Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi.
    Respir Res. 2017;18:61.
    PubMed     Abstract available

  247. KARL FM, Holle R, Bals R, Greulich T, et al
    Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.
    Respir Res. 2017;18:60.
    PubMed     Abstract available

  248. CORDOBA-LANUS E, Cazorla-Rivero S, Espinoza-Jimenez A, de-Torres JP, et al
    Telomere shortening and accelerated aging in COPD: findings from the BODE cohort.
    Respir Res. 2017;18:59.
    PubMed     Abstract available

    March 2017
  249. LEVAN TD, Smith LM, Heires AJ, Mikuls TR, et al
    Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers.
    Respir Res. 2017;18:49.
    PubMed     Abstract available

  250. ROOS AB, Mori M, Gura HK, Lorentz A, et al
    Increased IL-17RA and IL-17RC in End-Stage COPD and the Contribution to Mast Cell Secretion of FGF-2 and VEGF.
    Respir Res. 2017;18:48.
    PubMed     Abstract available

  251. NAMBA Y, Togo S, Tulafu M, Kadoya K, et al
    Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes.
    Respir Res. 2017;18:46.
    PubMed     Abstract available

    February 2017
  252. MARTINEZ CH, Freeman CM, Nelson JD, Murray S, et al
    GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
    Respir Res. 2017;18:42.
    PubMed     Abstract available

  253. BAZZAN E, Turato G, Tine M, Radu CM, et al
    Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity.
    Respir Res. 2017;18:40.
    PubMed     Abstract available

  254. WESTERIK JA, Metting EI, van Boven JF, Tiersma W, et al
    Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.
    Respir Res. 2017;18:31.
    PubMed     Abstract available

    January 2017
  255. ZARCONE MC, van Schadewijk A, Duistermaat E, Hiemstra PS, et al
    Diesel exhaust alters the response of cultured primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD) to non-typeable Haemophilus influenzae.
    Respir Res. 2017;18:27.
    PubMed     Abstract available

  256. CAZZOLA M, Calzetta L, Facciolo F, Rogliani P, et al
    Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
    Respir Res. 2017;18:26.
    PubMed     Abstract available

  257. BLASI F, Canonica GW, Miravitlles M
    Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?
    Respir Res. 2017;18:19.
    PubMed     Abstract available

  258. KAHNERT K, Lucke T, Biertz F, Lechner A, et al
    Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort.
    Respir Res. 2017;18:14.
    PubMed     Abstract available

  259. SALOMON J, Stolz D, Domenighetti G, Frey JG, et al
    Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.
    Respir Res. 2017;18:13.
    PubMed     Abstract available

  260. TOPALOVIC M, Exadaktylos V, Troosters T, Celis G, et al
    Non-linear parameters of specific resistance loops to characterise obstructive airways diseases.
    Respir Res. 2017;18:9.
    PubMed     Abstract available

  261. REISNER C, Fabbri LM, Kerwin EM, Fogarty C, et al
    A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension Delivery Technology in patients with moderate-to-very severe chronic obstruct
    Respir Res. 2017;18:8.
    PubMed     Abstract available

  262. DANG X, Qu X, Wang W, Liao C, et al
    Bioinformatic analysis of microRNA and mRNA Regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease.
    Respir Res. 2017;18:4.
    PubMed     Abstract available

  263. BATTAGLIA S, Scichilone N
    Eligibility of real-life patients with COPD for inclusion in RCTs: a commentary.
    Respir Res. 2017;18:5.
    PubMed     Abstract available

  264. SHUKLA SD, Mahmood MQ, Weston S, Latham R, et al
    The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL).
    Respir Res. 2017;18:6.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.